InterCure Stock (NASDAQ:INCR)


RevenueOwnershipFinancialsChart

Previous Close

$1.74

52W Range

$1.01 - $3.72

50D Avg

$1.89

200D Avg

$2.18

Market Cap

$79.40M

Avg Vol (3M)

$25.89K

Beta

0.06

Div Yield

-

INCR Company Profile


InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

270

IPO Date

Jan 28, 2019

Website

INCR Performance


INCR Financial Summary


Dec 23Dec 22Dec 21
RevenueILS355.55MILS388.68MILS219.68M
Operating IncomeILS-40.90MILS52.80MILS28.19M
Net IncomeILS-61.96MILS44.82MILS7.30M
EBITDAILS-27.74MILS64.50MILS37.58M
Basic EPSILS-1.36ILS0.99ILS0.16
Diluted EPSILS-1.36ILS0.99ILS0.16

Fiscal year ends in Dec 23 | Currency in ILS

Latest Earnings Call Transcripts


Q4 22Apr 04, 23 | 6:56 PM
Q2 22Aug 16, 22 | 2:11 PM
Q1 22May 17, 22 | 5:06 PM

Peer Comparison


TickerCompany
PAHCPhibro Animal Health Corporation
RGCRegencell Bioscience Holdings Limited
IXHLIncannex Healthcare Limited
SSICSilver Spike Investment Corp.
PBHPrestige Consumer Healthcare Inc.
PCRXPacira BioSciences, Inc.
COLLCollegium Pharmaceutical, Inc.
EGRXEagle Pharmaceuticals, Inc.